Rebecca L. Krain

Evaluating important change in cutaneous disease activity as an efficacy measure for clinical trials in dermatomyositis

Sarah Ahmed, Srita Chakka, Josef Symon S. Concha et al. · British Journal of Dermatology · 2019 · 37 citations · Full text

Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus

Srita Chakka, Rebecca L. Krain, Sarah Ahmed et al. · Journal of the American Academy of Dermatology · 2020 · 28 citations · Full text

Quality Of Life, Disease Management, Meaningful Improvement +9

Assessing the Correlation Between Disease Severity Indices and Quality of Life Measurement Tools in Pemphigus

Rebecca L. Krain, Carolyn J. Kushner, M. Tarazi et al. · Frontiers in Immunology · 2019 · 27 citations · Full text

Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus

Kristen L. Chen, Rebecca L. Krain, Victoria P. Werth · F1000Research · 2019 · 20 citations · Full text

Cutaneous lupus concerns from the patient perspective: a qualitative study

Daisy Yan, Danielle Zamalin, Srita Chakka et al. · Lupus Science & Medicine · 2021 · 15 citations · Full text